Asymmetric Unit (13, 13)
No. | Name | Evidence | Residues | Description |
01 | AC1 | SOFTWARE | CBV A:2 | binding site for residue NA A 101 |
02 | AC2 | SOFTWARE | CBV C:2 , C C:3 , HOH C:207 | binding site for residue NA C 101 |
03 | AC3 | SOFTWARE | CBV C:2 | binding site for residue NA C 102 |
04 | AC4 | SOFTWARE | G D:1 | binding site for residue NA D 101 |
05 | AC5 | SOFTWARE | G A:1 , G A:9 , C A:10 , HOH A:207 , C B:3 , C B:10 , HOH B:103 , HOH B:104 , HOH B:109 | binding site for Di-nucleotide G B 1 and CBV B 2 |
06 | AC6 | SOFTWARE | G A:8 , G A:9 , C A:10 , HOH A:207 , G B:1 , G B:4 , HOH B:109 , HOH B:111 , HOH B:115 | binding site for Di-nucleotide CBV B 2 and C B 3 |
07 | AC7 | SOFTWARE | G A:5 , 6MZ A:6 , G B:4 , U B:7 , HOH B:113 , G C:9 , C C:10 | binding site for Di-nucleotide G B 5 and 6MZ B 6 |
08 | AC8 | SOFTWARE | C C:3 , NA C:101 , NA C:102 , HOH C:206 , HOH C:207 , HOH C:210 , G D:9 , C D:10 | binding site for Di-nucleotide G C 1 and CBV C 2 |
09 | AC9 | SOFTWARE | C B:10 , G C:1 , G C:4 , NA C:101 , NA C:102 , HOH C:202 , HOH C:205 , HOH C:207 , HOH C:211 , G D:8 , G D:9 , C D:10 | binding site for Di-nucleotide CBV C 2 and C C 3 |
10 | AD1 | SOFTWARE | G C:4 , U C:7 , HOH C:208 , G D:5 , 6MZ D:6 , HOH D:205 , HOH D:208 | binding site for Di-nucleotide G C 5 and 6MZ C 6 |
11 | AD2 | SOFTWARE | G C:9 , C C:10 , HOH C:204 , C D:3 , NA D:101 , HOH D:207 , HOH D:214 | binding site for Di-nucleotide G D 1 and CBV D 2 |
12 | AD3 | SOFTWARE | U A:7 , G C:8 , G C:9 , C C:10 , G D:1 , G D:4 , HOH D:207 , HOH D:211 | binding site for Di-nucleotide CBV D 2 and C D 3 |
13 | AD4 | SOFTWARE | G C:5 , 6MZ C:6 , U C:7 , G D:4 , U D:7 , HOH D:201 , HOH D:204 , HOH D:205 , HOH D:208 , HOH D:212 | binding site for Di-nucleotide G D 5 and 6MZ D 6 |
|